Cardioprotection by Recombinant Human Erythropoietin Following Acute Experimental Myocardial Infarction: Dose Response and Therapeutic Window

By Moon Chanil   Krawczyk Melissa   Paik Doojin   Lakatta Edward   Talan Mark  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 4, 2005-08 ,pp. : 243-250

Springer Publishing Company

Access to resources Recommend Favorite

Improved survival with simendan after experimental myocardial infarction in rats

By Levijoki J.   Pollesello P.   Kaheinen P.   Haikala H.  

European Journal of Pharmacology, Vol. 419, Iss. 2, 2001-05 ,pp. : 243-248

Elsevier

Access to resources Recommend Favorite

METABOLISM OF CHLORAL HYDRATE IN MICE AND RATS AFTER SINGLE AND MULTIPLE DOSES

By Beland Frederick A.   Schmitt Thomas C.   Fullerton Nancy F.   Young John F.  

Journal of Toxicology and Environmental Health, Vol. 54, Iss. 3, 1998-06 ,pp. : 209-226

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study

By Lipšic Erik   Meer Peter   Voors Adriaan   Westenbrink B.   Heuvel Ad   Boer Hetty   Zonneveld Anton   Schoemaker Regien   Gilst Wiek   Zijlstra Felix   Veldhuisen Dirk  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 2, 2006-04 ,pp. : 135-141

Springer Publishing Company

Access to resources Recommend Favorite

Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats

By Mori T.   Nishimura H.   Okabe M.   Ueyama M.   Kubota J.   Kawamura K.  

European Journal of Pharmacology, Vol. 348, Iss. 2, 1998-05 ,pp. : 229-234

Elsevier

Access to resources Recommend Favorite